Stefan Glück, MD, PhD, FRCPC: HER2 + Metastatic Breast Cancer Patients and TDM-1

Dr. Glück sits down with Selma Schimmel in The Group Room. They discuss the amazing news coming out of ASCO 2013 for TDM-1 and how it is helping HER2+ metastatic breast cancer patients.

This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2013.

Stefan Glück, MD, PhD, FRCPC, Sylvester Distinguished Professor, Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Leonard M. Miller School of Medicine.

Advocacy and educational support provided at ASCO 2013, in part, by:

TGR ASCO 2013 Sponsor

Comments